StockNews.AI
ABL
StockNews.AI
73 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

1. Pomerantz LLP is investigating possible securities fraud at Abacus Global Management. 2. Morpheus Research report claims Abacus manufactures fake revenue through flawed methodologies. 3. Abacus's stock fell 21.47% to $6.00 per share following fraud allegations. 4. Concerns include changes in portfolio valuation and life expectancy estimates. 5. Historical red flags related to Abacus's co-founders were highlighted.

5m saved
Insight
Article

FAQ

Why Very Bearish?

The significant stock price drop indicates strong negative market reaction to allegations. Similar past cases, such as Herbalife, show substantial long-term damages when fraud is suspected.

How important is it?

Allegations of fraud directly impact investor sentiment and ABL's stock fundamentals. The ongoing investigation and market dynamics will likely shape ABL’s financial health.

Why Long Term?

Secrets and methodologies under scrutiny may lead to ongoing investigations, affecting future profitability and investor confidence. Historical context shows legal actions can take years to resolve.

Related Companies

SPACHBIHLF
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Abacus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On June 4, 2025, Morpheus Research a report entitled "Abacus Global Management: This $794 Million SPAC Is Yet Another Life Settlements Accounting Scheme Manufacturing Fake Revenue By Systematically Underestimating When People Will Die." The report alleges that Abacus incorporated a change in its portfolio valuation methodology to make Abacus appear more profitable that it actually is. The report also alleges that Abacus uses questionable methodologies for calculating life expectancy estimates and identified historical "red flags" associated with Abacus's co-founders.  On this news, Abacus's stock price fell $1.64 per share, or 21.47%, to close at $6.00 per share on June 5, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes. SOURCE Pomerantz LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News